Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.4 Entry and Fusion Inhibitors
1.2.5 Protease Inhibitors (PIs)
1.2.6 Integrase Inhibitors
1.2.7 Coreceptor Antagonists
1.3 Market by Application
1.3.1 Global HIV Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Therapeutics Market Perspective (2018-2033)
2.2 HIV Therapeutics Growth Trends by Region
2.2.1 Global HIV Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 HIV Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 HIV Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 HIV Therapeutics Market Dynamics
2.3.1 HIV Therapeutics Industry Trends
2.3.2 HIV Therapeutics Market Drivers
2.3.3 HIV Therapeutics Market Challenges
2.3.4 HIV Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Therapeutics Players by Revenue
3.1.1 Global Top HIV Therapeutics Players by Revenue (2018-2023)
3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Therapeutics Revenue
3.4 Global HIV Therapeutics Market Concentration Ratio
3.4.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2022
3.5 HIV Therapeutics Key Players Head office and Area Served
3.6 Key Players HIV Therapeutics Product Solution and Service
3.7 Date of Enter into HIV Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Therapeutics Breakdown Data by Type
4.1 Global HIV Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global HIV Therapeutics Forecasted Market Size by Type (2024-2033)
5 HIV Therapeutics Breakdown Data by Application
5.1 Global HIV Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global HIV Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America HIV Therapeutics Market Size (2018-2033)
6.2 North America HIV Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America HIV Therapeutics Market Size by Country (2018-2023)
6.4 North America HIV Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Therapeutics Market Size (2018-2033)
7.2 Europe HIV Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe HIV Therapeutics Market Size by Country (2018-2023)
7.4 Europe HIV Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific HIV Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific HIV Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific HIV Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Therapeutics Market Size (2018-2033)
9.2 Latin America HIV Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America HIV Therapeutics Market Size by Country (2018-2023)
9.4 Latin America HIV Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa HIV Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa HIV Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa HIV Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Detail
11.1.2 Boehringer Ingelheim International GmbH Business Overview
11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction
11.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2018-2023)
11.1.5 Boehringer Ingelheim International GmbH Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Detail
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. HIV Therapeutics Introduction
11.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2018-2023)
11.2.5 Merck & Co. Recent Development
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Company Detail
11.3.2 ViiV Healthcare Business Overview
11.3.3 ViiV Healthcare HIV Therapeutics Introduction
11.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2018-2023)
11.3.5 ViiV Healthcare Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie HIV Therapeutics Introduction
11.4.4 AbbVie Revenue in HIV Therapeutics Business (2018-2023)
11.4.5 AbbVie Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2018-2023)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2018-2023)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences HIV Therapeutics Introduction
11.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2018-2023)
11.8.5 Gilead Sciences Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson HIV Therapeutics Introduction
11.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2018-2023)
11.9.5 Johnson & Johnson Recent Development
11.10 Cipla Limited
11.10.1 Cipla Limited Company Detail
11.10.2 Cipla Limited Business Overview
11.10.3 Cipla Limited HIV Therapeutics Introduction
11.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2018-2023)
11.10.5 Cipla Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Key Players of Entry and Fusion Inhibitors
Table 5. Key Players of Protease Inhibitors (PIs)
Table 6. Key Players of Integrase Inhibitors
Table 7. Key Players of Coreceptor Antagonists
Table 8. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global HIV Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global HIV Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global HIV Therapeutics Market Share by Region (2018-2023)
Table 12. Global HIV Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global HIV Therapeutics Market Share by Region (2024-2033)
Table 14. HIV Therapeutics Market Trends
Table 15. HIV Therapeutics Market Drivers
Table 16. HIV Therapeutics Market Challenges
Table 17. HIV Therapeutics Market Restraints
Table 18. Global HIV Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global HIV Therapeutics Market Share by Players (2018-2023)
Table 20. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2022)
Table 21. Ranking of Global Top HIV Therapeutics Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by HIV Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players HIV Therapeutics Product Solution and Service
Table 25. Date of Enter into HIV Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global HIV Therapeutics Revenue Market Share by Type (2018-2023)
Table 29. Global HIV Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global HIV Therapeutics Revenue Market Share by Type (2024-2033)
Table 31. Global HIV Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global HIV Therapeutics Revenue Market Share by Application (2018-2023)
Table 33. Global HIV Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global HIV Therapeutics Revenue Market Share by Application (2024-2033)
Table 35. North America HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America HIV Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe HIV Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific HIV Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific HIV Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific HIV Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America HIV Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa HIV Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 50. Boehringer Ingelheim International GmbH Company Detail
Table 51. Boehringer Ingelheim International GmbH Business Overview
Table 52. Boehringer Ingelheim International GmbH HIV Therapeutics Product
Table 53. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 54. Boehringer Ingelheim International GmbH Recent Development
Table 55. Merck & Co. Company Detail
Table 56. Merck & Co. Business Overview
Table 57. Merck & Co. HIV Therapeutics Product
Table 58. Merck & Co. Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 59. Merck & Co. Recent Development
Table 60. ViiV Healthcare Company Detail
Table 61. ViiV Healthcare Business Overview
Table 62. ViiV Healthcare HIV Therapeutics Product
Table 63. ViiV Healthcare Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 64. ViiV Healthcare Recent Development
Table 65. AbbVie Company Detail
Table 66. AbbVie Business Overview
Table 67. AbbVie HIV Therapeutics Product
Table 68. AbbVie Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 69. AbbVie Recent Development
Table 70. F. Hoffmann-La Roche Ltd. Company Detail
Table 71. F. Hoffmann-La Roche Ltd. Business Overview
Table 72. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product
Table 73. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 74. F. Hoffmann-La Roche Ltd. Recent Development
Table 75. Teva Pharmaceutical Industries Ltd. Company Detail
Table 76. Teva Pharmaceutical Industries Ltd. Business Overview
Table 77. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product
Table 78. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 79. Teva Pharmaceutical Industries Ltd. Recent Development
Table 80. Bristol-Myers Squibb Company Detail
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb HIV Therapeutics Product
Table 83. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Gilead Sciences Company Detail
Table 86. Gilead Sciences Business Overview
Table 87. Gilead Sciences HIV Therapeutics Product
Table 88. Gilead Sciences Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 89. Gilead Sciences Recent Development
Table 90. Johnson & Johnson Company Detail
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson HIV Therapeutics Product
Table 93. Johnson & Johnson Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 94. Johnson & Johnson Recent Development
Table 95. Cipla Limited Company Detail
Table 96. Cipla Limited Business Overview
Table 97. Cipla Limited HIV Therapeutics Product
Table 98. Cipla Limited Revenue in HIV Therapeutics Business (2018-2023) & (US$ Million)
Table 99. Cipla Limited Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global HIV Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 4. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 5. Entry and Fusion Inhibitors Features
Figure 6. Protease Inhibitors (PIs) Features
Figure 7. Integrase Inhibitors Features
Figure 8. Coreceptor Antagonists Features
Figure 9. Global HIV Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global HIV Therapeutics Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Labs Case Studies
Figure 14. HIV Therapeutics Report Years Considered
Figure 15. Global HIV Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global HIV Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global HIV Therapeutics Market Share by Region: 2022 VS 2033
Figure 18. Global HIV Therapeutics Market Share by Players in 2022
Figure 19. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2022
Figure 21. North America HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America HIV Therapeutics Market Share by Country (2018-2033)
Figure 23. United States HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe HIV Therapeutics Market Share by Country (2018-2033)
Figure 27. Germany HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific HIV Therapeutics Market Share by Region (2018-2033)
Figure 35. China HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America HIV Therapeutics Market Share by Country (2018-2033)
Figure 43. Mexico HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa HIV Therapeutics Market Share by Country (2018-2033)
Figure 47. Turkey HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia HIV Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 50. Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 51. ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 52. AbbVie Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 53. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 56. Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 58. Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed